Palisade Bio ($PALI) Insider Trading & Smart Money Activity

Palisade Bio, Inc. · Latest filing Oct 2, 2026

Palisade Bio, Inc. ($PALI) has 2 insider trades on file. In the last 12 months on the open market, 1 insider bought ($28.80K) and no insider sold, net +$28.80K.

Insider buyers (12 mo)

1

Insider sellers (12 mo)

0

Net insider $ (12 mo)

+$28.80K

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

PALI insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	2 · $28.80K	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PALI insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 2, 2026	Insider	Williams Donald AllenDirector	Buy (Open-market buy)	10K sh	$14.60K						—
Oct 1, 2026	Insider	Williams Donald AllenDirector	Buy (Open-market buy)	10K sh	$14.20K						—

1W / 1M / 6M = how PALI moved from the trade or filing date.

Insider trading in PALI: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Williams Donald Allen	Director	2	+$28.80K		Oct 2, 2026

Frequently asked questions

Are PALI insiders buying or selling?

Over the last 12 months 1 insider made 2 open-market purchases worth $28.80K and 0 insiders made 0 open-market sales worth $0, a net +$28.80K.

What is the latest insider trade in PALI?

Williams Donald Allen, Director filed a buy (open-market buy) of 10K sh worth $14.60K on Oct 2, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.